AI tool mimics pathologists to improve breast cancer tissue analysis accuracyAI tool mimics pathologists to improve breast cancer tissue analysis accuracy
A research team led by two University of Maine Ph.D. students developed an artificial intelligence (AI) system that could make it easier and faster for doctors to identify signs of breast cancer in tissue samples, possibly preventing delays and saving lives.
STAT+: Novo Nordisk’s $199 Ozempic deal shows what telehealth platforms can do for pharmaSTAT+: Novo Nordisk’s $199 Ozempic deal shows what telehealth platforms can do for pharma
On Monday, Novo Nordisk announced a discount on its popular drugs for diabetes and obesity, Ozempic and Wegovy, cutting prices for the lowest doses to $199 when patients pay cash through Novo’s pharmacy NovoCare. Patients searching for those deals online, though, won’t always get funneled to the drugmaker’s sites. Instead, the first results they may Read More
Brain Activity on Zepbound; Alzheimer’s and Chris Hemsworth; Autism-Gut Link QueriedBrain Activity on Zepbound; Alzheimer’s and Chris Hemsworth; Autism-Gut Link Queried
(MedPage Today) — Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after taking tirzepatide (Zepbound), showing the medication suppressed brain signaling associated with food… (MedPage Today) — Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after taking tirzepatide (Zepbound), showing the medication Read More
Drug Cuts Nausea From GLP-1 Drugs; ‘Female Viagra’ Boom; Semaglutide and Alcohol UseDrug Cuts Nausea From GLP-1 Drugs; ‘Female Viagra’ Boom; Semaglutide and Alcohol Use
(MedPage Today) — Vanda Pharmaceuticals said its investigational neurokinin-1 receptor antagonist tradipitant reduced nausea and vomiting from semaglutide (Ozempic, Wegovy) in a randomized trial of people with obesity or overweight. A KFF poll… (MedPage Today) — Vanda Pharmaceuticals said its investigational neurokinin-1 receptor antagonist tradipitant reduced nausea and vomiting from semaglutide (Ozempic, Wegovy) in Read More
Breast Cancer and Birth Control: A Huge New Study Shows How Science Can Be DistortedBreast Cancer and Birth Control: A Huge New Study Shows How Science Can Be Distorted
(MedPage Today) — As misinformation about women’s health spreads faster than ever, doctors say new research on the risks of hormonal birth control underscores the challenge of communicating nuance in the social media age.
The massive study, which…
Navigating Second-Line Endocrine Options in Breast CancerNavigating Second-Line Endocrine Options in Breast Cancer
(MedPage Today) — The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is becoming increasingly complex, with decisions now shaped by ESR1 and PIK3CA mutations, CDK4/6 inhibitor exposure…
A case study on cravings and a GLP-1A case study on cravings and a GLP-1
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. As a reminder, STAT’s Isabella Cueto and J. Emory Parker are keeping track of every promise made by health secretary Robert F. Kennedy Jr. about reworking American health care. They just updated their tracker with Read More
Breast Cancer and Birth Control: A Huge New Study Shows How Science Can Be DistortedBreast Cancer and Birth Control: A Huge New Study Shows How Science Can Be Distorted
The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the results won’t change how they counsel patients.
Amazon scorpion venom shows stunning power against breast cancerAmazon scorpion venom shows stunning power against breast cancer
Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From Amazonian scorpions yielding molecules that kill breast cancer cells as effectively as chemotherapy, to improved fibrin sealants and custom-grown bioactive factors, researchers are pushing biotechnology into uncharted territory. Parallel teams are advancing radiotheranostics that diagnose and destroy tumors with precision, while others forge experimental vaccines that train the immune system using hybrid dendritic cells.
Breast cancer treatments can improve both survival chances and incomeBreast cancer treatments can improve both survival chances and income
Radiation therapy treatment for breast cancer not only improves survival rates but also generates long-term financial benefits, according to a new study from the University of Copenhagen.